Colon Cancer News and Research

Latest Colon Cancer News and Research

Commensal gut microbes from IBD patients produce genotoxic metabolites

Functional screening of human gut microbiota reveals a family of small molecule genotoxins called indolimines in patients with inflammatory bowel disease (IBD), according to a new study.

27 Oct 2022

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Colorectal cancer is one of the most common cancers. Its treatment is mainly based on chemotherapy. However, over time, chemotherapy induces resistance in the majority of patients, who end up being unresponsive to the drugs.

27 Oct 2022

Physical exercise improves cardiorespiratory fitness, alleviates adverse effects of cancer treatment

During chemotherapy, physical exercise intervention is safe, improves long-term cardiorespiratory fitness, and alleviates some of the adverse effects of cancer treatment, according to a study published in JACC: CardioOncology.

18 Oct 2022

Researchers identify a new gene essential to colon cancer growth

Researchers at Mount Sinai's Tisch Cancer Institute have identified a new gene that is essential to colon cancer growth and found that inflammation in the external environment around the tumor can contribute to the growth of tumor cells.

17 Oct 2022

Poll shows high interest, uneven use of direct-to-consumer medical tests

Kitchen counters and bathroom sinks across America turned into miniature medical testing labs over the past year, as millions of people swabbed their noses and found out in minutes if they had COVID-19.

13 Oct 2022

Are men or women impacted more by adverse reactions to prescription drug treatments?

Recently, researchers presented an overview of sex-based differences in adverse drug reactions (ADRs) based on epidemiology, technique, and underlying mechanism data.

11 Oct 2022

Is aspirin linked to higher rates of survival for cancer patients?

Researchers discussed the existing evidence on the use of acetylsalicylic acid (aspirin) in cancer treatment.

19 Sep 2022

Using Q-bodies for imaging intracellular proteins in live cells

Recent advances in imaging technology have made it possible to visualize intracellular dynamics, which offers a better understanding of several key biological principles for accelerating therapeutic development.

9 Sep 2022

Physical activity may help improve outcomes for colon cancer patients after surgery

Physical activity may be associated with improved outcomes for patients undergoing postoperative treatment for Stage III colon cancer.

8 Sep 2022

Discovery sheds light on an important aspect of gut health and mucosal immunity

Immune cells called group 3 innate lymphoid cells (ILC3s) play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.

7 Sep 2022

Lactate may have a previously unrecognized role in fighting cancer

A new study by UT Southwestern's Simmons Cancer Center scientists suggests that lactate, a metabolic byproduct produced by cells during strenuous exercise, can rejuvenate immune cells that fight cancer.

6 Sep 2022

Ultra-processed food may increase colorectal cancer risk in men

A new study reveals that high consumption of ultra-processed foods might increase the risk of colorectal cancer in men.

2 Sep 2022

Hackensack Meridian Health becomes second in the world to implant Impella Bridge-to-Recovery heart pump

Hackensack Meridian Health, Hackensack University Medical Center cardiac surgeon Yuriy Dudiy, M.D. became the second in the world to successfully implant the Impella Bridge-to-Recovery (BTR)™ heart pump for the technology's U.S. Food and Drug Administration (FDA) early feasibility study (EFS) investigational device exemption (IDE).

17 Aug 2022

Study paves new way to develop a predictive biomarker for TRAIL therapy

A cytokine named TRAIL binds to TRAIL receptors and kills cancer cells, but not normal cells. Therefore, various anticancer drugs targeting TRAIL receptors have been developed and gained great attention as a promising cancer therapeutics, but a certain population of cancer patients does not respond to the therapy.

15 Aug 2022

Research identifies unique vulnerabilities in ALT cancers that can serve as novel therapeutic targets

In a study recently published in Cancer Research, a journal of the American Association for Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the Texas Tech University Health Sciences Center School of Medicine Cancer Center, sought to expand upon his lab's previous research that showed ALT tumors identified by a biomarker known as C-circles share a common biology that confers vulnerabilities to be exploited for cancer therapy.

10 Aug 2022

Optical coherence tomography combined with machine learning to develop colorectal cancer imaging tool

A research team from the lab of Quing Zhu, the Edwin H. Murty Professor of Engineering in the Department of Biomedical Engineering at the McKelvey School of Engineering at Washington University in St. Louis, has combined optical coherence tomography (OCT) and machine learning to develop a colorectal cancer imaging tool that may one day improve the traditional endoscopy currently used by doctors.

4 Aug 2022

Research could pave the way for therapeutic strategies targeting DCIR to treat colorectal tumors

Colorectal tumors are a common adverse effect of chronic inflammation of the intestine. In a new study, researchers from Japan and China demonstrate that mice models with dendritic cell immunoreceptor (DCIR) protein deficiency are resistant to colonic tumors induced by dextran sodium sulfate and azoxymethane.

2 Aug 2022

TransCode and MD Anderson scientists collaborate to validate therapeutic and diagnostic candidates

The University of Texas MD Anderson Cancer Center and TransCode Therapeutics, Inc. today announced a strategic alliance to advance TransCode's pipeline of RNA-targeted oncology therapeutic and diagnostic candidates.

2 Aug 2022

People eating more fiber-rich food have very healthy microbiomes, study shows

That huge array of dietary fiber supplements in the drugstore or grocery aisle can be overwhelming to a consumer. They make all sorts of health claims too, not being subject to FDA review and approval. So how do you know which supplement works and would be best for you?

29 Jul 2022

International Agency for Research on Cancer classifies firefighting as carcinogenic

The International Agency for Research on Cancer recently classified occupational exposure as a firefighter as carcinogenic, changing the previous classification of possibly carcinogenic.

20 Jul 2022

Colon Cancer News and Research

Latest Colon Cancer News and Research

Commensal gut microbes from IBD patients produce genotoxic metabolites

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Physical exercise improves cardiorespiratory fitness, alleviates adverse effects of cancer treatment

Researchers identify a new gene essential to colon cancer growth

Poll shows high interest, uneven use of direct-to-consumer medical tests

Are men or women impacted more by adverse reactions to prescription drug treatments?

Is aspirin linked to higher rates of survival for cancer patients?

Using Q-bodies for imaging intracellular proteins in live cells

Physical activity may help improve outcomes for colon cancer patients after surgery

Discovery sheds light on an important aspect of gut health and mucosal immunity

Lactate may have a previously unrecognized role in fighting cancer

Ultra-processed food may increase colorectal cancer risk in men

Hackensack Meridian Health becomes second in the world to implant Impella Bridge-to-Recovery heart pump

Study paves new way to develop a predictive biomarker for TRAIL therapy

Research identifies unique vulnerabilities in ALT cancers that can serve as novel therapeutic targets

Optical coherence tomography combined with machine learning to develop colorectal cancer imaging tool

Research could pave the way for therapeutic strategies targeting DCIR to treat colorectal tumors

TransCode and MD Anderson scientists collaborate to validate therapeutic and diagnostic candidates

People eating more fiber-rich food have very healthy microbiomes, study shows

International Agency for Research on Cancer classifies firefighting as carcinogenic

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Colon Cancer News and Research

Latest Colon Cancer News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in